Zimmer Biomet Holdings Current Ratio 2012-2025 | ZBH
Current and historical current ratio for Zimmer Biomet Holdings (ZBH) from 2012 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Zimmer Biomet Holdings current ratio for the three months ending December 31, 2025 was 0.00.
| Zimmer Biomet Holdings Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2025-12-31 | $5.12B | $2.58B | 1.98 |
| 2025-09-30 | $5.84B | $2.40B | 2.43 |
| 2025-06-30 | $5.05B | $2.70B | 1.87 |
| 2025-03-31 | $5.59B | $2.30B | 2.44 |
| 2024-12-31 | $4.67B | $2.45B | 1.91 |
| 2024-09-30 | $4.86B | $3.57B | 1.36 |
| 2024-06-30 | $4.64B | $3.61B | 1.29 |
| 2024-03-31 | $4.63B | $2.80B | 1.66 |
| 2023-12-31 | $4.61B | $2.86B | 1.61 |
| 2023-09-30 | $4.37B | $2.07B | 2.11 |
| 2023-06-30 | $4.39B | $2.23B | 1.96 |
| 2023-03-31 | $4.41B | $2.34B | 1.89 |
| 2022-12-31 | $4.43B | $2.36B | 1.88 |
| 2022-09-30 | $4.53B | $2.30B | 1.98 |
| 2022-06-30 | $4.46B | $2.46B | 1.81 |
| 2022-03-31 | $4.52B | $2.67B | 1.69 |
| 2021-12-31 | $4.89B | $3.47B | 1.41 |
| 2021-09-30 | $5.31B | $2.94B | 1.81 |
| 2021-06-30 | $5.36B | $2.93B | 1.83 |
| 2021-03-31 | $5.00B | $2.09B | 2.39 |
| 2020-12-31 | $5.08B | $2.56B | 1.99 |
| 2020-09-30 | $5.15B | $2.27B | 2.27 |
| 2020-06-30 | $4.71B | $2.16B | 2.18 |
| 2020-03-31 | $6.37B | $3.78B | 1.69 |
| 2019-12-31 | $4.72B | $3.44B | 1.37 |
| 2019-09-30 | $4.40B | $3.77B | 1.17 |
| 2019-06-30 | $4.39B | $3.68B | 1.19 |
| 2019-03-31 | $4.50B | $2.26B | 2.00 |
| 2018-12-31 | $4.43B | $2.42B | 1.83 |
| 2018-09-30 | $4.51B | $2.39B | 1.89 |
| 2018-06-30 | $4.48B | $1.85B | 2.41 |
| 2018-03-31 | $5.78B | $3.43B | 1.69 |
| 2017-12-31 | $4.57B | $3.07B | 1.49 |
| 2017-09-30 | $4.43B | $3.01B | 1.47 |
| 2017-06-30 | $4.42B | $3.00B | 1.48 |
| 2017-03-31 | $5.08B | $2.66B | 1.91 |
| 2016-12-31 | $4.66B | $2.38B | 1.96 |
| 2016-09-30 | $4.70B | $2.31B | 2.03 |
| 2016-06-30 | $5.05B | $2.10B | 2.40 |
| 2016-03-31 | $5.08B | $1.52B | 3.36 |
| 2015-12-31 | $5.85B | $1.62B | 3.62 |
| 2015-09-30 | $6.40B | $1.79B | 3.58 |
| 2015-06-30 | $6.75B | $2.16B | 3.12 |
| 2015-03-31 | $11.92B | $0.91B | 13.12 |
| 2014-12-31 | $4.31B | $1.02B | 4.21 |
| 2014-09-30 | $4.33B | $1.09B | 3.96 |
| 2014-06-30 | $4.23B | $0.95B | 4.44 |
| 2014-03-31 | $4.05B | $0.92B | 4.41 |
| 2013-12-31 | $4.20B | $1.03B | 4.07 |
| 2013-09-30 | $3.84B | $0.80B | 4.77 |
| 2013-06-30 | $3.59B | $0.80B | 4.47 |
| 2013-03-31 | $3.46B | $0.76B | 4.54 |
| 2012-12-31 | $3.71B | $0.87B | 4.28 |
| 2012-09-30 | $3.63B | $0.76B | 4.81 |
| 2012-06-30 | $3.48B | $0.68B | 5.09 |
| 2012-03-31 | $3.32B | $0.86B | 3.86 |
| 2011-12-31 | $3.28B | $0.87B | 3.78 |
| 2011-09-30 | $3.07B | $0.68B | 4.56 |
| 2011-06-30 | $3.11B | $0.68B | 4.58 |
| 2011-03-31 | $3.03B | $0.71B | 4.25 |
| 2010-12-31 | $3.01B | $0.70B | 4.28 |
| 2010-09-30 | $3.01B | $0.70B | 4.31 |
| 2010-06-30 | $2.98B | $0.60B | 4.96 |
| 2010-03-31 | $2.87B | $0.66B | 4.39 |
| 2009-12-31 | $2.74B | $0.69B | 3.96 |
| 2009-09-30 | $2.45B | $0.68B | 3.62 |
| 2009-06-30 | $2.33B | $0.67B | 3.48 |
| 2009-03-31 | $2.20B | $0.70B | 3.12 |
| 2008-12-31 | $2.18B | $0.77B | 2.83 |
| 2008-09-30 | $2.33B | $0.84B | 2.78 |
| 2008-06-30 | $2.21B | $0.81B | 2.73 |
| 2008-03-31 | $2.22B | $0.79B | 2.82 |
| 2007-12-31 | $2.08B | $0.75B | 2.78 |
| 2007-09-30 | $1.90B | $0.71B | 2.69 |
| 2007-06-30 | $1.95B | $0.64B | 3.03 |
| 2007-03-31 | $1.89B | $0.60B | 3.15 |
| 2006-12-31 | $1.75B | $0.63B | 2.78 |
| 2006-09-30 | $1.71B | $0.68B | 2.51 |
| 2006-06-30 | $1.79B | $0.63B | 2.84 |
| 2006-03-31 | $1.83B | $0.57B | 3.21 |
| 2005-12-31 | $1.58B | $0.61B | 2.60 |
| 2005-09-30 | $1.50B | $0.66B | 2.29 |
| 2005-06-30 | $1.49B | $0.61B | 2.43 |
| 2005-03-31 | $1.48B | $0.61B | 2.43 |
| 2004-12-31 | $1.56B | $0.70B | 2.23 |
| 2004-09-30 | $1.30B | $0.59B | 2.21 |
| 2004-06-30 | $1.33B | $0.54B | 2.46 |
| 2004-03-31 | $1.36B | $0.57B | 2.41 |
| 2003-12-31 | $1.34B | $0.65B | 2.08 |
| 2003-09-30 | $0.81B | $0.40B | 2.03 |
| 2003-06-30 | $0.76B | $0.40B | 1.90 |
| 2003-03-31 | $0.58B | $0.34B | 1.68 |
| 2002-12-31 | $0.61B | $0.40B | 1.53 |
| 2002-09-30 | $0.61B | $0.39B | 1.56 |
| 2002-06-30 | $0.61B | $0.40B | 1.53 |
| 2002-03-31 | $0.55B | $0.38B | 1.46 |
| 2001-12-31 | $0.51B | $0.37B | 1.36 |
| 2001-09-30 | $0.50B | $0.39B | 1.29 |
| 2001-06-30 | $0.45B | $0.40B | 1.14 |
| 2001-03-31 | $0.00B | 0.00 | |
| 2000-09-30 | $0.00B | 0.00 | |
| 2000-06-30 | $0.00B | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $19.115B | $8.232B |
| Zimmer Biomet is a leading musculoskeletal healthcare company that designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $195.936B | 21.88 |
| EssilorLuxottica (ESLOY) | France | $142.091B | 0.00 |
| Stryker (SYK) | United States | $140.083B | 26.86 |
| Medtronic (MDT) | Ireland | $127.548B | 17.67 |
| Boston Scientific (BSX) | United States | $110.783B | 24.50 |
| Medline (MDLN) | United States | $58.526B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.093B | 0.00 |
| ResMed (RMD) | United States | $36.791B | 24.57 |
| GE HealthCare Technologies (GEHC) | United States | $36.615B | 17.54 |
| Agilent Technologies (A) | United States | $35.584B | 22.55 |
| Koninklijke Philips (PHG) | Netherlands | $30.091B | 17.86 |
| Terumo (TRUMY) | Japan | $21.610B | 25.26 |
| Insulet (PODD) | United States | $17.076B | 53.00 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $15.372B | 0.00 |
| Baxter (BAX) | United States | $10.182B | 8.72 |
| Sunny Optical Technology (SNPTF) | China | $8.485B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.921B | 25.86 |
| Demant (WILYY) | Denmark | $6.042B | 0.00 |
| Envista Holdings (NVST) | United States | $4.747B | 24.14 |
| Lantheus Holdings (LNTH) | United States | $4.601B | 14.02 |
| BillionToOne (BLLN) | United States | $4.056B | 0.00 |
| ICU Medical (ICUI) | United States | $3.577B | 22.71 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.263B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.160B | 14.91 |
| Haemonetics (HAE) | United States | $2.684B | 11.74 |
| Neogen (NEOG) | United States | $2.380B | 52.10 |
| Phibro Animal Health (PAHC) | United States | $2.118B | 18.66 |
| Perrigo (PRGO) | Ireland | $2.001B | 5.01 |
| LeMaitre Vascular (LMAT) | United States | $1.989B | 40.03 |
| Curaleaf Holdings (CURLF) | Canada | $1.642B | 0.00 |
| AtriCure (ATRC) | United States | $1.623B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.602B | 11.12 |
| Kestra Medical Technologies (KMTS) | United States | $1.571B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.446B | 63.36 |
| AdaptHealth (AHCO) | United States | $1.381B | 20.00 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.358B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.070B | 317.57 |
| Capricor Therapeutics (CAPR) | United States | $1.026B | 0.00 |
| InMode (INMD) | Israel | $0.906B | 9.93 |
| Tilray Brands (TLRY) | Canada | $0.875B | 0.00 |
| Valneva SE (VALN) | France | $0.868B | 0.00 |
| Omeros (OMER) | United States | $0.829B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.757B | 0.00 |
| CeriBell (CBLL) | United States | $0.733B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.566B | 13.52 |
| Brainsway (BWAY) | Israel | $0.451B | 76.63 |
| Canopy Growth (CGC) | Canada | $0.436B | 0.00 |
| Cerus (CERS) | United States | $0.430B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.396B | 0.00 |
| SNDL (SNDL) | Canada | $0.386B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.361B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.328B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.315B | 25.09 |
| Evolus (EOLS) | United States | $0.279B | 0.00 |
| Quanterix (QTRX) | United States | $0.268B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.243B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Sanuwave Health (SNWV) | United States | $0.213B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.205B | 18.42 |
| High Tide (HITI) | Canada | $0.203B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.201B | 59.17 |
| OraSure Technologies (OSUR) | United States | $0.197B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.182B | 0.00 |
| Organigram Global (OGI) | Canada | $0.174B | 0.00 |
| Accendra Health (ACH) | United States | $0.173B | 1.74 |
| Vireo Growth (VREOF) | United States | $0.170B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.168B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Apyx Medical (APYX) | United States | $0.142B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.134B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.129B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.42 |
| MacroGenics (MGNX) | United States | $0.108B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.100B | 0.00 |
| Biote (BTMD) | United States | $0.097B | 4.26 |
| Exagen (XGN) | United States | $0.074B | 0.00 |
| ImmuCell (ICCC) | United States | $0.060B | 25.39 |
| Sharps Technology (STSS) | United States | $0.051B | 0.00 |
| Nephros (NEPH) | United States | $0.044B | 31.54 |
| Cytosorbents (CTSO) | United States | $0.040B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.040B | 0.00 |
| Veru (VERU) | United States | $0.037B | 0.00 |
| Modular Medical (MODD) | United States | $0.035B | 0.00 |
| United-Guardian (UG) | United States | $0.030B | 15.35 |
| Jin Medical (ZJYL) | China | $0.022B | 0.00 |
| Bonk (BNKK) | United States | $0.021B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.014B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| INLIF (INLF) | China | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Agape ATP (ATPC) | $0.002B | 0.00 | |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |